Literature DB >> 18164653

Strain-specific antibody response to Lassa virus in the local population of west Africa.

Petra Emmerich1, Stephan Günther, Herbert Schmitz.   

Abstract

BACKGROUND: Lassa virus (LAV) isolates obtained from Sierra Leone, Ivory Coast and Nigeria show a high degree of amino acid difference [Gunther S, Weisner B, Roth A, Grewing T, Asper M, Drosten C, et al. Lassa fever encephalopathy: Lassa virus in cerebrospinal fluid but not in serum. J Infect Dis 2001;184:345-9]. Therefore, three LAV strains from Sierra Leone, Ivory Coast and Nigeria were used as antigens to study the anti-LAV antibody response in 960 serum samples obtained from different regions of west Africa. STUDY
DESIGN: The antibody response to LAV was studied both by a standard indirect immunofluorescence assay (IFA) and by a highly sensitive reverse ELISA [Emmerich P, Thome-Bolduan C, Drosten C, Gunther S, Ban E, Sawinsky I, et al. Reverse ELISA for IgG and IgM antibodies to detect Lassa virus infections in Africa. J Clin Virol 2006;37:227-81].
RESULTS: In 88 of the 960 subjects from west African countries (Guinea, Liberia, Ivory Coast, Ghana, Benin, and Nigeria) anti-Lassa antibodies were detected with both assays. Significant titer differences and clustering analysis revealed strain-specific antibodies in 64 of the 88 positive samples. Depending on the geographic origin of the samples, up to 32% of anti-LAV antibody positive samples would not have been detected, if only the IFA had been run with LAV prototype strain Josiah. In 20 patients with acute Lassa fever differences in antibody titer between the three LAV antigens were not observed.
CONCLUSIONS: Our data suggest that antigens prepared of regional LAV strains should be applied when seroprevalence studies are conducted in various parts of west Africa.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18164653     DOI: 10.1016/j.jcv.2007.11.019

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  16 in total

Review 1.  Laboratory Diagnosis of Lassa Fever.

Authors:  Vanessa Raabe; Jeffrey Koehler
Journal:  J Clin Microbiol       Date:  2017-04-12       Impact factor: 5.948

2.  The first cases of Lassa fever in Ghana.

Authors:  E K Dzotsi; S-A Ohene; F Asiedu-Bekoe; J Amankwa; B Sarkodie; M Adjabeng; A M Thouphique; A Ofei; J Oduro; D Atitogo; J H K Bonney; S C N Paintsil; W Ampofo
Journal:  Ghana Med J       Date:  2012-09

3.  Imported Lassa fever: a report of 2 cases in Ghana.

Authors:  Nicholas N A Kyei; Mark M Abilba; Foster K Kwawu; Prince G Agbenohevi; Joseph H K Bonney; Thomas K Agbemaple; Shirley C Nimo-Paintsil; William Ampofo; Sally-Ann Ohene; Edward O Nyarko
Journal:  BMC Infect Dis       Date:  2015-05-29       Impact factor: 3.090

4.  Risk Factors Associated with Ebola and Marburg Viruses Seroprevalence in Blood Donors in the Republic of Congo.

Authors:  Nanikaly Moyen; Laurence Thirion; Petra Emmerich; Amelia Dzia-Lepfoundzou; Hervé Richet; Yannik Boehmann; Yannick Dimi; Pierre Gallian; Ernest A Gould; Stephan Günther; Xavier de Lamballerie
Journal:  PLoS Negl Trop Dis       Date:  2015-06-05

Review 5.  Vaccines for epidemic infections and the role of CEPI.

Authors:  Stanley A Plotkin
Journal:  Hum Vaccin Immunother       Date:  2017-04-04       Impact factor: 3.452

6.  Alphavirus vector-based replicon particles expressing multivalent cross-protective Lassa virus glycoproteins.

Authors:  Min Wang; Jenny Jokinen; Irina Tretyakova; Peter Pushko; Igor S Lukashevich
Journal:  Vaccine       Date:  2017-12-26       Impact factor: 3.641

Review 7.  Serological assays based on recombinant viral proteins for the diagnosis of arenavirus hemorrhagic fevers.

Authors:  Shuetsu Fukushi; Hideki Tani; Tomoki Yoshikawa; Masayuki Saijo; Shigeru Morikawa
Journal:  Viruses       Date:  2012-10-12       Impact factor: 5.048

8.  Sensorineural hearing loss in Lassa fever: two case reports.

Authors:  Peter O Okokhere; Titus S Ibekwe; George O Akpede
Journal:  J Med Case Rep       Date:  2009-01-29

9.  Lassa Virus Seroprevalence in Sibirilia Commune, Bougouni District, Southern Mali.

Authors:  Nafomon Sogoba; Kyle Rosenke; Jennifer Adjemian; Sory Ibrahim Diawara; Ousmane Maiga; Moussa Keita; Drissa Konaté; Abdoul Salam Keita; Ibrahim Sissoko; Matt Boisen; Diana Nelson; Darin Oottamasathien; Molly Millett; Robert F Garry; Luis M Branco; Sékou F Traoré; Seydou Doumbia; Heinz Feldmann; David Safronetz
Journal:  Emerg Infect Dis       Date:  2016-04       Impact factor: 6.883

10.  Control measures following a case of imported Lassa fever from Togo, North Rhine Westphalia, Germany, 2016.

Authors:  Clara Lehmann; Matthias Kochanek; Diana Abdulla; Stephan Becker; Boris Böll; Anne Bunte; Daniel Cadar; Arno Dormann; Markus Eickmann; Petra Emmerich; Torsten Feldt; Christina Frank; Jochen Fries; Martin Gabriel; Udo Goetsch; René Gottschalk; Stephan Günther; Michael Hallek; Dieter Häussinger; Christian Herzog; Björn Jensen; Felix Kolibay; Michael Krakau; Georg Langebartels; Toni Rieger; Lars Schaade; Jonas Schmidt-Chanasit; Edgar Schömig; Gundolf Schüttfort; Alexander Shimabukuro-Vornhagen; Michael von Bergwelt-Baildon; Ulrike Wieland; Gerhard Wiesmüller; Timo Wolf; Gerd Fätkenheuer
Journal:  Euro Surveill       Date:  2017-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.